Ubrogepant | m-entrepreneurship.com

Product Name :
Ubrogepant

Search keywords :
Calcitonin receptor

drugId :
null

Target Vo:
Calcitonin gene-related peptide receptor

Target Vo Short Name :
CGRPR

Moa_Name:
Calcitonin gene-related peptide receptor antagonists

First Approval Country :
United States

First Approval Date Filter:
2019

Origin Company_Name :
Merck Sharp & Dohme Corp

Active Company_Name :
Abbvie Inc

Active Indication_Name:
Migraine Disorders

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Mepolizumab In Vitro
CD38 Rabbit mAb Purity & Documentation
eIF4G1 Antibody: eIF4G1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 175 kDa, targeting to eIF4G1. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts